TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada

NCT00323492 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Truvada
DRUG: Current HAART regimen

Sponsor

Gilead Sciences